RSS

TECO Treaty Energy Corporation

Last Post: 03/24/22
Followers: 93
Posts Today: 0
Views Today: 6581

TECO Stock Quote & Tools

$— ▲ +0.0000 (+0.00%)
Last—
$ Chg0.0000
Open—
High—
Beta-167.3862
Year High0.009
Market Cap—
P/B Ratio—
EPS—
Avg Vol (30d)1.55M
Volume—
% Chg+0.00%
Prev Close—
Low—
VWAP—
Year Low0.000
Total Shares—
Shares Out—
Float2.13B
Exchange
Energy Fossil Fuels

TECO Stock Message Board Discussion

  1. Kanola
  2. BULL2222

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 60

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 153

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 90

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

The Future of Hybrid Powertrains: Market Insights and Forecast

Updated Category News Views 309

Overview of the Hybrid Powertrain Market The Hybrid Powertrain Market is set for remarkable growth over the next decade, driven by a surge in demand for eco-friendly, fuel-efficient vehicles globally. Industry experts highlight the innovative strides made by prominent players like Hyundai Motor Company, Honda Motor Co., Ltd., Ford Motor Company, and Toyota Motor...

Continue Reading
Discover the Unique Aston Martin Valkyrie Auctioned by Ricciardo

Updated Category News Views 227

Aston Martin Valkyrie: A Hypercar Marvel Broad Arrow Auctions is set to showcase an exceptional hypercar, the Aston Martin Valkyrie, at its inaugural Zoute Concours Auction. This stunning vehicle was personally commissioned and driven by the celebrated Formula One driver, Daniel Ricciardo. Not only is this Valkyrie a piece of automotive artwork, but it also holds a rich...

Continue Reading
Defense Mobility Lifted as Rubber Tracks Gain Traction

Updated Category News Views 36

Rubber Tracks Are Shaping Tomorrow’s Battlefields Defense agencies, faced with a world that's perpetually bristling with tension, need solutions that are light on their feet—literally. As luck would have it, rubber track technology seems to be offering just what the tactical doctor ordered, paving the way for a chunk of the defense sector to trot steadily towards a...

Continue Reading
Strategic Partnership to Transform Auto Insurance Industry

Updated Category News Views 77

YSX TECH. CO., LTD Forms Strategic Alliance with Huijian YSX TECH. CO., LTD (NASDAQ: YSXT), a notable entity providing comprehensive business solutions primarily for insurance firms in China, has recently embarked on an exciting venture with Huijian Information Technology Co., Ltd. This strategic alliance marks a significant move in the realm of auto insurance and supply...

Continue Reading
Peabody Class Action: Investors Eye Lead Role

Updated Category News Views 57

Peabody Energy Awash in Legal Turmoil There’s a storm brewing over at Peabody Energy, and it’s not coal dust causing the ruckus this time. Investors are eyeing an opportunity to step into the driver’s seat of a class action lawsuit, pointing fingers at Peabody for alleged securities law violations. If you got your skin scorched between October 14, 2024, and May 4,...

Continue Reading